Navdar Sever

Dr. Sever is a Research Associate at Harvard Medical School. He has Over 15 years of experience in cholesterol metabolism, signal transduction, protein and lipid biochemistry. During his postdoctoral research, he has Initiated lentiviral-based genome-scale CRISPR-Cas9 knockout screening to identify novel components of Hedgehog and Wnt pathways; discovered natural lipid sources with potent Hedgehog pathway inhibitory activity; scaled up fractionation and purification of a bioactive lipid; thoroughly characterized the purified species using chemical, enzymatic, chromatographic and spectroscopic methods; synthesized lipids in vitro to confirm structure and biological activity; identified mammalian analogues of the purified lipid and verified their biological activity; provided a new mechanistic explanation for an inherited metabolic disorder where accumulation of certain lipids give rise to birth defects.

Lab Information

Navdar Sever-Harvard Medical School

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Biochemistry 0 Genetics 0 Molecular Biology 0 Cell Biology 0

More

  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (1)


This guy hasn’t posted anything yet.

Hot Posts for You

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections. NAbs can bind to sites on the virus and inhibit entry of that virus into the host. It is a key parameter to evaluate COVID-19 vaccine efficacy per Guidelines from Development and ...Learn More


This 3D animation shows you how DNA is copied in a cell. It shows how both strands of the DNA helix are unzipped and copied to produce two identical DNA molecules. TranscriptDNA is a molecule made up of two strands twisted around each other in a double helix shape. Each strand is ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


  1. Sever N, Mann RK, Xu L, Snell WJ, Hernandez-Lara CI, Porter NA, Beachy PA (2016) A novel mode of Smoothened inhibition by endogenous B-ring oxysterols in Hedgehog signaling. Proc Natl Acad Sci USA (published ahead of print May 9, 2016)

  2. Strating JR, van der Linden L, Albulescu L, Bigay J, Arita M, Delang L, Leyssen P, van der Schaar HM, Lanke KH, Thibaut HJ, Ulferts R, Drin G, Schlinck N, Wubbolts RW, Sever N, Head SA, Liu JO, Beachy PA, De Matteis MA, Shair MD, Olkkonen VM, Neyts J, van Kuppeveld FJ. (2015) Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Rep 10, 600-15.

  3. Kim J, Hsia EY, Kim J, Sever N, Beachy PA, Zheng X. (2014) Simultaneous measurement of Smoothened entry into and exit from the primary cilium. PLoS One 9:e104070.

  4. Myers BR, Sever N, Chong YC, Kim J, Belani JD, Rychnovsky S, Bazan JF, Beachy PA. (2013) Hedgehog pathway modulation by multiple lipid binding sites on the Smoothened effector of signal response. Dev Cell 26, 346-57.

  5. Zheng X, Mann RK, Sever N, Beachy PA. (2010) Genetic and biochemical definition of the Hedgehog receptor. Genes Dev 24, 57-71.

  6. Dwyer JR, Sever N, Carlson M, Nelson SF, Beachy PA, Parhami F. (2007) Oxysterols are novel activators of the Hedgehog signaling pathway in pluripotent mesenchymal cells. J Biol Chem 282, 8959-68.

  7. Song BL, Sever N, DeBose-Boyd RA. (2005) Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol Cell 19, 829-40.

  8. Lee PC, Sever N, DeBose-Boyd RA. (2005) Isolation of sterol-resistant Chinese hamster ovary cells with genetic deficiencies in both Insig-1 and Insig-2. J Biol Chem 280, 25242-9.

  9. Sever N, Lee PC, Song BL, Rawson RB, DeBose-Boyd RA. (2004) Isolation of cells lacking Insig-1 through selection with SR-12813, an agent that stimulates degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem 279, 43136-47.

  10. Sever N, Song BL, Yabe D, Goldstein JL, Brown MS, DeBose-Boyd RA. (2003) Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem 278, 52479-90.

  11. Sever N, Yang T, Brown MS, Goldstein JL, DeBose-Boyd RA. (2003) Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell 11, 25-33.


This guy hasn’t plasmids anything yet.

Hot plasmids


This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2025 MolecularCloud